Request a Demo
Please fill out this form and an associate will contact you shortly.
Thank You. Your request has been received by our response team. You will hear from us soon.Close this tab

Boardof Directors

Meet the thought leaders who are changing what is possible in healthcare, manufacturing, and retail.

Click photos for details

X
Tim Roche
President & CEO

Tim is the president and chief executive officer at Awarepoint Corporation and has served as chief financial officer since November 2011.

Prior to Awarepoint, Tim was the co-founder, president and chief executive officer of MDdatacor, inc., a healthcare information technology company that enhances healthcare quality through the development of innovative technology solutions to support such programs as pay-for-performance, clinical integration and care coordination, and the patient-centered medical home. With more than 25 years experience as an entrepreneur, Tim has a successful track record in starting, financing and managing innovative high-growth companies. He has secured more than $150 million in private and public equity financing for various companies in the technology and health care industries.

Prior senior management positions include: (i) chief financial officer of BrightLane.com, (ii) chief financial officer, treasurer and secretary of eCompanyStore.com, (iii) vice president of finance and corporate controller at Biofield Corp., (iv) controller of Dianon Systems, Inc. and (v) senior supervisor at Arthur Andersen LLP.

Tim is a certified public accountant. (Inactive Status)

Brian Ascher
Venrock

Brian Ascher joined Venrock in 1998 as a Kauffman Fellow and is currently a partner based in Palo Alto. Brian focuses on enterprise information technology and healthcare IT. In addition to Awarepoint, Brian is also on the board of healthcare IT company Vocera (NYSE: VCRA) and he was a past director of RelayHealth up until its acquisition by McKesson. Brian also serves on the Boards of Retail SolutionsInrixBillfloatPersonal Capital, and Atrenta; and previous investments include ADiFY (acquired by Cox Enterprises), DATAllegro (acquired by Microsoft), Unicru (acquired by Kronos), and Red Beacon (acquired by The Home Depot.) Prior to Venrock, Brian was a Senior Product Manager at Intuit responsible for Quicken and Quicken.com, and earlier in his career was a Strategy Consultant at the Monitor Group. Brian has been named to the Forbes Midas List, which ranks the top venture capitalists, multiple times including the current edition.

Brian received his B.A. from Princeton and his M.B.A. from Stanford.

Hear more from Brian >> YouTube video: "The rationale behind placing money today"

Brandon Hull
Cardinal Partners

Brandon Hull is co-founder and Managing Partner of Cardinal Partners, a medical and life sciences venture capital partnership established in 1996. He began his career as a VC in 1991 as a principal of the Edison Venture Fund, where he directed Edison's healthcare investing activities and served on the boards of its healthcare portfolio companies. His extensive investment experience includes all facets of health care services, health care information systems, medical products & devices, and encompasses a variety of information technology sectors outside of health care. Brandon was a first-round investor in such notable companies as Athenahealth, Coderyte, Visicu, and Intellicare.

Prior to his venture investing experience, Brandon spent seven years in health services operations. Brandon has served on the boards of numerous healthcare and medical technology companies, and currently serves as a director of AthenaHealth (Lead Director), Awarepoint, CureAtr, QPID, and Fluidnet, and is a board observer of Teladoc.

Brandon received his BA in Philosophy and Literature from Wheaton College and his MBA from The Wharton School of the University of Pennsylvania.

Dana Mead
Kleiner Perkins Caufield & Byers

Dana Mead joined Kleiner Perkins Caufield & Byers as a partner in May 2005 to work in the firm's life sciences practice. He leverages experience accrued from his venture-funded, startup management roles and board participation to support entrepreneurs and innovators. Dana serves on the boards of Apnicure, Awarepoint, Corventis, Inspire Medical Systems, Intersect ENT, Invuity, Pulmonx, Spiracur, Spinal Modulation, and Teladoc.

For the past 30 years, Dana's career has focused on identifying new medical technologies, developing new markets and therapies, and building world-class management teams. He has worked with physician thought leaders around the world representing 10 medical specialties. Before joining KPCB, Dana was president of Guidant Vascular Intervention, a fully integrated billion-dollar division with more than 4,500 employees. He currently serves on the boards of the California Healthcare Institute and Lucile Packard Children's Hospital at Stanford University, and he is the chair of the Lafayette College West Coast Advisory Council.

A native of Connecticut, Dana received his bachelor of arts degree from Lafayette College and holds an MBA from the University of Southern California.

Paul Wallace
Heritage Group

Paul Wallace joined Heritage in 2011 as a Managing Director for the Heritage Healthcare Innovation Fund. Prior to joining Heritage, Mr. Wallace served as a Venture Partner for SV Life Sciences, a $2 billion international private equity firm investing exclusively in health care. From 2003 - 2009, he served as SVP Sales & Marketing and SVP Corporate Development for Healthways, Inc. (NASDAQ: HWAY). During this time, Healthways completed more than 15 strategic transactions, and revenue increased from $120 million to more than $700 million.

Prior to joining Healthways, Mr. Wallace was a General Partner of Petra Capital Partners, a $120m private equity investment firm in Nashville, TN. From 1997-2001, he was a founding member and Managing Director with New York-based Gilbert Global Equity Partners, a $1.2 billion global private equity fund created with the former investment team of Soros Capital. Prior to GGEP, Mr. Wallace was a Vice President with Lazard Asia Investment Management, a Singapore-based $250 million private equity fund focused on growth equity investments in Asia. Prior to Lazard, he served as an Associate with Golder, Thoma, Cressey, Rauner (GTCR), a $4 billion private equity firm based in Chicago. Earlier in his career, he served as a Commercial Lending Officer with Bank of America.

He received his M.B.A. from the Kellogg Graduate School of Management and his B.A. from the University of Richmond. He is a native of Nashville, where he resides with his wife and three children.

Tom Mawhinney
Icon Ventures

Tom Mawhinney joined Icon Ventures in 2003 as a general partner, bringing a 15-year background in the technology industry as both a venture capitalist (with Summit Partners and Canaan Partners) and an entrepreneur (having run North Systems for five years). Having been in the "startup world" for more than 20 years when he joined the Awarepoint Board of Directors, he brings a passion for helping to scale young, rapidly growing companies.

Prior investment successes include 41st Parameter (Experian), AmeriPath (PATH), Brion Technoligies (ASML), ClairMail (Monitise), DATAllegro (Microsoft), Infinera (INFN), IntelliQuest (IQST), Microbank Software (SunGard Data Systems), Mimosa Systems (Iron Mountain), Pediatrix Medical Group (PDX), PostPath (Cisco Systems), Powerwave Technologies (PWAV), Solidcore Systems (McAfee), SteriGenics International (STER) and Voltage Security (Hewlett-Packard). Current investments include Bill.com, Groundwork, Huddle, KIXEYE, MarketLive, Reputation.com, Synack, Teladoc and Yodle.

Tom received his MBA from the Stanford Graduate School of Business and graduated with honors with a Bachelor of Arts degree from Harvard College.

Vijay Lathi
New Leaf Venture Partners

Vijay Lathi is a managing director at New Leaf Venture Partners concentrating primarily on information convergence and diagnostics investments. New Leaf was a spin-off of Sprout in 2005; Vijay joined Sprout in 1998.

Vijay also serves on the boards of iRhythm Technologies, Kitcheck Health, Oxford Immunotec, Advanced Cell Diagnostics, and Expression Diagnostics. Prior to joining Sprout, Vijay worked as an analyst in the Healthcare Venture Capital Group at Robertson Stephens & Co. and Cornerstone Research, a consulting firm focused on financial and economic analysis for business litigation. Previous investments include ePocrates (NASDAQ: EPOC, acquired by Athenahealth), Focus Diagnostics (acquired by Quest Diagnostics), and Ilypsa (acquired by Amgen).

Vijay graduated from the Massachusetts Institute of Technology and Stanford University where he received his bachelor of science and master of science degrees in Chemical Engineering, with an emphasis on the application of engineering to life science technology. Vijay is also a member of AiCHE.

Terry Linn
Senior Healthcare Executive

​Terry is a senior healthcare executive with over 40 years of experience in many facets of healthcare including corporate development, strategy, financial and clinical operations, mergers and acquisitions, capital finance, supply chain, population health and information technology applications. Terry has served as a consultant and adviser to large not-for-private and public healthcare companies, served as a senior corporate development and strategy executive for two different public companies and led the IPO and corporate restructuring of one of these companies.  Terry has been a founder of three start-up healthcare companies and helped lead and govern these companies in their development.

Terry’s key leadership positions are summarized below.

•       Senior VP Corporate Development and Strategy, Premier, Inc. 2009-2015
•       Chief Development Officer, Hospital Partners of America, 2003-2009
•       Regional Healthcare Consulting Practice Leader and Partner, Ernst & Young, 1978-1993 and 1998-2002
•       Chief Development Officer, American Medical International, 1993-1995​